Cargando…

Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers

A molecular mimicry between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human proteins supports the possibility that autoimmunity takes place during coronavirus disease 2019 (COVID-19) contributing to tissue damage. For example, anti-phospholipid antibodies (aPL) have been repor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borghi, Maria Orietta, Bombaci, Mauro, Bodio, Caterina, Lonati, Paola Adele, Gobbini, Andrea, Lorenzo, Mariangela, Torresani, Erminio, Dubini, Antonella, Bulgarelli, Ilaria, Solari, Francesca, Pregnolato, Francesca, Bandera, Alessandra, Gori, Andrea, Parati, Gianfranco, Abrignani, Sergio, Grifantini, Renata, Meroni, Pier Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334668/ https://www.ncbi.nlm.nih.gov/pubmed/35911726 http://dx.doi.org/10.3389/fimmu.2022.930074

Ejemplares similares

Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
por: Borghi, Maria Orietta, et al.
Publicado: (2020)

Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination
por: Lonati, Paola Adele, et al.
Publicado: (2022)

Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis
por: Raschi, Elena, et al.
Publicado: (2020)

The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study
por: Favalli, Ennio Giulio, et al.
Publicado: (2022)

Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study
por: Favalli, Ennio Giulio, et al.
Publicado: (2022)

Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome
por: Lonati, Paola Adele, et al.
Publicado: (2019)

Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response
por: Pesce, Elisa, et al.
Publicado: (2022)

Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations
por: Favalli, Andrea, et al.
Publicado: (2022)

CombiROC: an interactive web tool for selecting accurate marker combinations of omics data
por: Mazzara, Saveria, et al.
Publicado: (2017)

Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations
por: Meroni, Pier Luigi, et al.
Publicado: (2014)

Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
por: Raschi, Elena, et al.
Publicado: (2018)

Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
por: Meroni, Pier Luigi, et al.
Publicado: (2023)

Comments on “PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person Living With HIV”
por: Lombardi, Andrea, et al.
Publicado: (2023)

Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations
por: Verde, Federico, et al.
Publicado: (2022)

New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats
por: Durigutto, Paolo, et al.
Publicado: (2019)

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome
por: Ripoll, Vera M., et al.
Publicado: (2018)

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
por: Pericleous, Charis, et al.
Publicado: (2016)

Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids
Publicado: (1981)

Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome
por: Volkov, Ilan, et al.
Publicado: (2020)

Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome
por: Grossi, Claudia, et al.
Publicado: (2023)

Antiphospholipid Antibody Assays in 2021: Looking for a Predictive Value in Addition to a Diagnostic One
por: Meroni, Pier Luigi, et al.
Publicado: (2021)

Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers
por: Roggenbuck, Dirk, et al.
Publicado: (2016)

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
por: Tedesco, Francesco, et al.
Publicado: (2018)

Effectiveness and Tolerability of Repeated Courses of Viscosupplementation in Symptomatic Hip Osteoarthritis: A Retrospective Observational Cohort Study of High Molecular Weight vs. Medium Molecular Weight Hyaluronic Acid vs. No Viscosupplementation
por: De Lucia, Orazio, et al.
Publicado: (2019)

Complement activation and endothelial perturbation parallel COVID-19 severity and activity
por: Cugno, Massimo, et al.
Publicado: (2021)

Interaction Study of Phospholipid Membranes with an N-Glucosylated β-Turn Peptide Structure Detecting Autoantibodies Biomarkers of Multiple Sclerosis
por: Becucci, Lucia, et al.
Publicado: (2015)

TMEM123 a key player in immune surveillance of colorectal cancer
por: Pesce, Elisa, et al.
Publicado: (2023)

Corrigendum: TMEM123 a key player in immune surveillance of colorectal cancer
por: Pesce, Elisa, et al.
Publicado: (2023)

Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis
por: Knütter, Ilka, et al.
Publicado: (2012)

The Frontal Assessment Battery (FAB) effectively discriminates between MCI and dementia within the clinical spectrum of neurochemically confirmed Alzheimer’s disease
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

β2 glycoprotein I participates in phagocytosis of apoptotic neurons and in vascular injury in experimental brain stroke
por: Grossi, Claudia, et al.
Publicado: (2021)

Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study
por: Lombardi, Andrea, et al.
Publicado: (2021)

Antiphospholipid autoantibodies in Lyme disease arise after scavenging of host phospholipids by Borrelia burgdorferi
por: Gwynne, Peter J., et al.
Publicado: (2022)

Group B streptococcal meningitis in an adult: A possible complication of olecranon bursitis
por: Colosimo, Manuela, et al.
Publicado: (2014)

A Rapid and Sensitive Method to Measure the Functional Activity of Shiga Toxins in Human Serum
por: Arfilli, Valentina, et al.
Publicado: (2015)

Therapeutic Potential of the Gut Microbiota in the Management of Sepsis
por: Bassetti, Matteo, et al.
Publicado: (2020)

Giant Lysosomes as a Chemotherapy Resistance Mechanism in Hepatocellular Carcinoma Cells
por: Colombo, Federico, et al.
Publicado: (2014)

Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism
por: Adorni, Maria Pia, et al.
Publicado: (2023)

Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation
por: Pagani, Lisa, et al.
Publicado: (2023)

Qualitative Immune Modulation by Interleukin-2 (IL-2) Adjuvant Therapy in Immunological Non Responder HIV-Infected Patients
por: Sabbatini, Francesca, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1vtsi9jb57ufqr5g2gtdb31vl6